Taipei, Sunday, February 7, 2016 21:19 (GMT+8)
sunny
Taipei
17°C
Taiwan PCB makers ramping up capacity - related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES [Monday 19 November 2012]
  • Apex Biotechnology
  • Performance
    The company's stock price closed at NT$42.5 on the TSE on Thursday, February 4, 2016.
    The company has reported consolidated revenues of NT$162 million for January 2016, representing a 17.4% increase on month and 2.2% increase on year.
    For the third quarter of 2015, the company totaled NT$471 million in consolidated revenues, up 11.3% sequentially and up 10% on year.
    Brief

    Full name: Apex Biotechnology

    Chinese name: 五鼎生物技術股份有限公司

    Short name: Apex

    Stock code: 1733

    Tax ID: 16130182

    Market: TSE

    Established: 2 Dec 1997

    Paid in capital: NT$985.31 million

    Listed on TSE: 17 Sep 2001

    Website: www.apexbio.com

  • Latest stock
    Apex [1733] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    5-Feb 20   42.50 42.75 42.20 42.50-0.15-0.35%  
    4-Feb 20   42.50 42.75 42.20 42.50-0.15-0.35%  
    3-Feb 20   42.50 42.75 42.20 42.50-0.15-0.35%  
    2-Feb 41 25 1,754,974 42.70 42.90 42.65 42.65-0.05-0.12% 42.95 42.60
    1-Feb 51 56 2,187,613 43.15 43.15 42.70 42.70-0.40-0.93% 43.00 42.70
    29-Jan 38 34 1,600,611 41.50 42.20 41.50 42.15+0.55+1.32% 42.15 42.00
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Jan 2015 - Jan 2016 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Jan-16

    162

    17.4%

    2.2%

    162

    2.2%

    Dec-15

    138

    (16.2%)

    (19.2%)

    1,847

    3.3%

    Nov-15

    165

    (6.8%)

    3.1%

    1,709

    5.7%

    Oct-15

    177

    11.9%

    7.4%

    1,545

    5.9%

    Sep-15

    158

    4.8%

    14%

    1,368

    5.7%

    Aug-15

    151

    (6.9%)

    19.5%

    1,210

    4.8%

    Jul-15

    162

    16.7%

    (0.8%)

    1,059

    2.9%

    Jun-15

    139

    8.6%

    (10.1%)

    897

    3.7%

    May-15

    128

    (18.3%)

    (20.4%)

    758

    6.6%

    Apr-15

    156

    (14.2%)

    22.6%

    631

    14.5%

    Mar-15

    182

    36.4%

    31.7%

    474

    12.1%

    Feb-15

    134

    (15.8%)

    5.9%

    292

    2.5%

    Jan-15

    159

    (7.2%)

    (0.2%)

    159

    (0.2%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, February 2016

    Apex: Consolidated revenues, 3Q14 - 3Q15 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    3Q-15

    471

    11.3%

    10%

    1,368

    5.7%

    2Q-15

    423

    (10.9%)

    (4.4%)

    897

    3.7%

    1Q-15

    474

    (4.3%)

    12.1%

    474

    12.1%

    4Q-14

    495

    15.7%

    39.8%

    1,789

    (2.2%)

    3Q-14

    428

    (3.2%)

    (5.8%)

    1,294

    (12.3%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, February 2016

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 3Q14 - 3Q15 (NT$k)

    Item

    3Q-2015

    2Q-2015

    1Q-2015

    4Q-2014

    3Q-2014

    Current assets

    1,380,889

    1,546,525

    1,513,288

    1,432,012

    1,443,777

    Intangible assets

    28,109

    28,756

    30,804

    30,521

    30,974

    Non-current assets

    1,150,182

    1,172,865

    1,194,194

    1,212,882

    1,239,343

    Assets

    2,531,071

    2,719,390

    2,707,482

    2,644,894

    2,683,120

    Current liabilities

    305,180

    997,962

    779,492

    752,294

    873,784

    Non-current liabilities

    400,163

    24,418

    25,322

    26,228

    27,365

    Liabilities

    705,343

    1,022,380

    804,814

    778,522

    901,149

    Stockholders' equity

    1,825,728

    1,697,010

    1,902,668

    1,866,372

    1,781,971

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, February 2016

    Apex: Consolidated income statement, 3Q14 - 3Q15 (NT$k)

    Item

    3Q-2015

    2Q-2015

    1Q-2015

    4Q-2014

    3Q-2014

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

     

     

    0

     

     

     

     

     

     

     

    Operating revenue

    470,705

     

    422,810

     

    474,282

     

    495,347

     

    428,083

     

    Gross profit (loss) from operations

    141,328

     

    113,292

     

    120,840

     

    145,823

     

    126,088

     

    Operating expenses

    58,773

     

    59,501

     

    57,767

     

    70,142

     

    57,677

     

    Operating income (loss)

    82,555

     

    53,791

     

    63,073

     

    75,681

     

    68,411

     

    Non-operating expenses and losses

    45,505

     

    -5,762

     

    -19,875

     

    23,037

     

    6,053

     

    Income from continuing operations before income tax

    128,060

     

    48,029

     

    43,198

     

    98,718

     

    74,464

     

    Net income (loss)

    108,829

     

    40,815

     

    36,704

     

    83,468

     

    60,904

     

    Diluted earnings per share (NT$)

    1

     

    0.4

     

    0.4

     

    0.8

     

    0.6

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, February 2016

  • Apex Biotechnology full profile

5-Feb-2016 markets closed

 LastChange

TAIEX (TSE)8063-68.24-0.84% 

TSE electronic322.21-1.06-0.33% 

GTSM (OTC)123.72-0.80-0.64% 

OTC electronic153.44-1.34-0.87% 

The Big Fund
Wireless broadband developments in Southeast Asia markets
The transition to 4k TV - UHD TV market forecast, 2014-2017
  • Wireless broadband developments in Southeast Asia markets

    As of 2013, the 10 ASEAN nations had a total of over 700 million mobile subscriptions, with the CAGR from 2003-2013 reaching 24%. This Digitimes Research Special Report analyzes the various mobile broadband markets in ASEAN and looks at the respective trends in 4G LTE development for those markets.

  • 2015 global tablet demand forecast

    This Digitimes Research Special Report provides a 2015 forecast for the global tablet market and analyzes the strategies of key market players such as Google, Apple, Intel, and Microsoft.

  • 2015 China smartphone panel trend forecast

    This Digitimes Research Special Report analyzes the strategies of key China-based major panel makers BOE, Tianma and IVO for attacking the different market segments through technology and pricing, and their relationship to local vendors Huawei, Lenovo, ZTE, Xiaomi and Coolpad.